This study is currently not recruiting participants.

A Double-Blind Randomized Controlled Dose Escalation Clinical Trial of an Antiplaque Chewing Gum- Phase 1 Safety and Tolerability and Phase 2a Safety Tolerability and Proof of Concept in a Gingivitis Population

Study on Safety of Investigational Chewing Gum

Not Recruiting
18 years - 64 years
All
Phase N/A
1 Location

Brief description of study.

purpose of this study is to see if chewing Antiplaque Chewing Gum is safe.

Detailed description of study

purpose of this study is to see if chewing Antiplaque Chewing Gum is safe.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Gingivitis
  • Age: 18 years - 64 years
  • Gender: All

This study investigates the safety of using an investigational chewing gum. The purpose is to determine if chewing this gum is safe for participants.

Participants will be asked to chew the investigational gum as part of the study procedures. The study will monitor for any side effects or reactions.

  • Who can participate: No specific criteria. Open to individuals willing to participate.
  • Study details: Participants will chew the investigational gum and report any side effects or reactions. Monitoring for side effects or reactions will be conducted throughout the study.
Updated on 19 Feb 2024. Study ID: 1305011355

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team